Journal Guide

Targeted toward those in the fields of neurology, family medicine, otolaryngology, and pediatrics, Neurologic Clinics offers a broad view of current practice, as well as the evidence to support it. Published quarterly — in February, May, August, and November — each issue focuses on a single topic neurology, including hearing loss, cholesteatoma, rhinology, anosmia, dysphagia, and pediatric-specific ENT.

Neurology, Psychiatry & Brain Research publishes original papers and reviews in neurology, biologically oriented psychiatry and psychotherapy, neuropsychoimmunology, neuropsychiatry and the neurosciences. Interdisciplinary and translational research is particularly appreciated.Neurology, Psychiatry & Brain Research is the oldest German journal in this field – it was founded in 1878 as the Centralblatt für Nervenheilkunde, Psychiatrie und gerichtliche Psychopathologie. Building on this long tradition, Elsevier has taken over publication of NPBR as of Vol. 17 (2011).NPBR offers optional open peer-reviews and communication by high-ranking scientists (CI > 20). Authors are encouraged to submit their manuscript in their native language as supplemental data to the English version.For your interest: Article "Mild encephalitis underlying psychiatric disorder - A reconsideration and hypothesis exemplified on Borna Disease." Neurol Psychiatry Brain Res 9: 55-70 from Prof. Karl Bechter is available as PDF.http://www.elsevier-data.de/journals/Bechter_K_2001_ME_Hypothesis_NPBR.pdf

Neurología, founded in 1986, is the official scientific Journal of the Spanish Neurology Society (Sociedad Española de Neurología, SEN).It is edited by Dr. Jorge Matías-Guiu and is indexed in the most important international data bases, such as Science Citation Index or Index Medicus/MEDLINE.The Journal accepts works on basic as well applied research on any field of neurology.Editor-in-Chief: J. Matías-Guiu.

Neurología, founded in 1986, is the official scientific Journal of the Spanish Neurology Society (Sociedad Española de Neurología, SEN). It is edited by Dr. Jorge Matías-Guiu and is indexed in the most important international data bases, such as Science Citation Index or Index Medicus/MEDLINE. The Journal accepts works on basic as well applied research on any field of neurology.

Neurología Argentina is the official Journal of the Argentine Neurological Society (Sociedad Neurología Argentina), affiliated to the World Neurology Foundation. Without a doubt, it is one of the most prestigious journals of the specialty in the Spanish language and covers topics related to neurology and neurosciences. Original articles, reviews and case reports are subject to peer review before publishing. It also contains Letters to the Editor and other sections which are dealt directly by the Editorial Committee. The Journal also contains a section, Continuing Medical Education Questions, which actively promotes the continuing education of the reader.

This international, multidisciplinary journal covers all aspects of neuromuscular disorders in childhood and adult life (including the muscular dystrophies, spinal muscular atrophies, hereditary neuropathies, congenital myopathies, myasthenias, myotonic syndromes, metabolic myopathies and inflammatory myopathies).The Editors welcome original articles from all areas of the field:• Clinical aspects, such as new clinical entities, case studies of interest, treatment, management and rehabilitation (including biomechanics, orthotic design and surgery).• Basic scientific studies of relevance to the clinical syndromes, including advances in the fields of molecular biology and genetics.• Studies of animal models relevant to the human diseases.The journal is aimed at a wide range of clinicians, pathologists, associated paramedical professionals and clinical and basic scientists with an interest in the study of neuromuscular disorders.In addition to original research papers, the journal also publishes reviews and mini-reviews, preliminary short communications and book reviews, and has editorial, correspondence and news sections. Reports on congresses and workshops, taking the form of a digested or very comprehensive commentary, pointing out some of the particular highlights in relation to the contributors and giving some detail of the area covered, important contributions and a list of participants, are also welcome.The journal is published monthly and aims at rapid publication of high quality papers of scientific merit as well as general interest to a wide readership. There is also a fast track for rapid publication of new material of outstanding scientific merit and importance.Neuromuscular Disorders is the official journal of the World Muscle Society an international, multidisciplinary, scientific society, dedicated to the advancement and dissemination of knowledge in the field of neuromuscular disorders.

The aim of Neuropeptides is the rapid publication of original research and review articles, dealing with the structure, distribution, actions and functions of peptides in the central and peripheral nervous systems. The explosion of research activity in this field has led to the identification of numerous naturally occurring endogenous peptides which act as neurotransmitters, neuromodulators, or trophic factors, to mediate nervous system functions. Increasing numbers of non-peptide ligands of neuropeptide receptors have been developed, which act as agonists or antagonists in peptidergic systems.The journal provides a unique opportunity of integrating the many disciplines involved in all neuropeptide research. The journal publishes articles on all aspects of the neuropeptide field, with particular emphasis on gene regulation of peptide expression, peptide receptor subtypes, transgenic and knockout mice with mutations in genes for neuropeptides and peptide receptors, neuroanatomy, physiology, behaviour, neurotrophic factors, preclinical drug evaluation, clinical studies, and clinical trials.Original papers predominate. Manuscripts may be of any length, but must be complete studies; preliminary communications are not accepted. Review articles and hypothesis papers are welcomed, and will be evaluated in the same way as experimental papers. Authors intending to submit a review are advised to communicate their intentions to the Editor, to avoid possible duplication.

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).Neuropharmacology also publishes succinct topical reviews on subjects within its remit. These reviews (of between 3000 and 5000 words) are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief ahead of time of their intention to submit a review and to indicate clearly how the review differs from, and adds to, recent published reviews on related topics. On the basis of the case made by authors, potential overlap with planned Neuropharmacology content, and discussions with the Editorial Team, the Editor-in-Chief will provide authors with a decision regarding their proposed review as quickly as possible.The scope of the journal is broad. It covers many disciplines and spans molecules (e.g., molecular biology, biochemistry) through systems (e.g., neurophysiology) to behaviour (e.g. cognition, psychopharmacology). The journal covers all aspects of neuroscience with an emphasis on neurotransmitters and their receptors, ion channels, signalling, psychcopharmacology and animal models of disease, such as investigations on the neurobiology of cognition, depression, schizophrenia, anxiety, epilepsy, ischaemia, neuroprotection, neurodegeneration, drugs of abuse and pain.The journal publishes occasional Special Issues (and will consider publishing Supplements). Each year Elsevier/Neuropharmacology organise a satellite symposium to the Meeting of the Society for Neuroscience. The journal publishes a Special Issue to accompany each meeting. Please see http://www.neuropharmacology-conference.elsevier.com/ for details of this year's meeting and accompanying Special Issue.US National Institutes of Health (NIH) voluntary posting ("Public Access") policyNeuropharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors

Organ of the 'Société française de psychiatrie de l'enfant et de l'adolescent', Neuropsychiatrie de l'enfance et de l'adolescence tackles all fields of child-adolescent psychiatry and offers a link between field and clinical work.As a reference and training tool for students and practitioners, the journal publishes original papers in child psychiatry as well as book reviews and conference reports.Each issue also offers a calendar of the main events dealing with the speciality.

Neuropsychologia is an international interdisciplinary journal devoted to experimental and theoretical contributions that advance understanding of human cognition and behavior from a neuroscience perspective. The journal will consider for publication studies that link brain function with cognitive processes, including attention and awareness, action and motor control, executive functions and cognitive control, memory, language, and emotion and social cognition.Neuropsychologia has a long history of publishing lesion-deficit studies, and these remain highly appropriate for the journal. Submission of papers describing the use of other methodologies – most notably functional and structural neuroimaging, cognitive electrophysiology, and transcranial magnetic stimulation - is strongly encouraged, however. Animal studies are also welcome, provided they have a direct and explicitly specified impact on understanding human cognition and behavior. Studies of clinical populations that are primarily descriptive or intended to elucidate a clinical disorder, or that evaluate a therapeutic intervention, are not appropriate for the journal. Special issues and Review Papers are published regularly with the aim of providing authoritative surveys of topics of major interest.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Neuroscience publishes papers describing the results of original research on any aspect of the scientific study of the nervous system. Any paper, however short, will be considered for publication provided that it reports significant, new and carefully confirmed findings with full experimental details.

The journal publishes review articles which are original and significant and deal with all aspects of neuroscience, where the relationship to the study of psychological processes and behavior is clearly established. Conversely, the journal will also publish articles whose primary focus deals with psychological processes and behavior, and which have relevance to one or more aspects of neuroscience.Submissions to the journal are actively encouraged which deal with topics not only in the more traditional areas, but also in the following areas, whenever the reviews bring new insights into brain-behavior relations:• Neuropsychology• Cognitive neuroscience• Brain imaging• In vivo monitoring of the brain's electrical and biochemical activities• Molecular biology• Genetics• NeurocomputationTheoretical articles and mini-reviews, for which the scope and literature coverage are more restricted, will also be published. We do not publish empirical papers. We welcome review articles from clinical researchers whose submission exceeds the high quality threshold for the journal and significantly advances our understanding of a field.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Neuroscience Letters is devoted to the rapid publication of short, high-quality papers of interest to the broad community of neuroscientists. Only papers which will make a significant addition to the literature in the field will be published. Papers in all areas of neuroscience - molecular, cellular, developmental, systems, behavioral and cognitive, as well as computational - will be considered for publication. Submission of laboratory investigations that shed light on disease mechanisms is encouraged. Clinical studies will also be published if they provide new information about organization or actions of the nervous system, or provide new insights into the neurobiology of disease.Papers that are primarily devoted to psychological or philosophical questions, that use unvalidated methodology, or that fall outside of the realm of neuroscience, will not be published.Neuroscience Letters is published both on the web (in ScienceDirect - http://www.sciencedirect.com), and as a print journal. Publication in the web version of Neuroscience Letters will occur within five weeks of acceptance, and in the hard copy within seven weeks. Particularly important papers may be published more rapidly within a Plenary Article section of the journal.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Neuroscience Research is an international journal for high quality articles in all branches of neuroscience, from the molecular to the behavioral levels. The journal is published in collaboration with the Japan Neuroscience Society and is open to all contributors in the world.

Neurosurgery Clinics of North America updates you on the latest surgical techniques for patients with spine, brain, and central nervous system conditions; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. Published in January, April, July, and October, each issue focuses on a single topic in neurosurgery and is presented under the direction of an editor who is in the forefront of clinical practice and research. Topics include brain tumors/neuro-oncology, cerebrovascular, movement disorders, neuroimaging, neuroradiology, pain, pediatric neurosurgery, peripheral nerve, pituitary, spine, stroke-related conditions, trauma and critical care, surgical techniques, and the skull base.

Neurotherapeutics® is the journal of the American Society for Experimental NeuroTherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders, written by international authorities.  The Journal also includes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field. Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues. Future Issue ThemesJanuary 2013 - Multiple Sclerosis
Guest Editor: Rohit Bakshi (BWH/Harvard)April 2013 - Mitochondrial Mechanisms in Neurologic Disease
Guest Editor: Andrea Gropman (Children’s National Medical Center) July 2013 - Protein Misfoldi

Neurotoxicology and Teratology provides a forum for publishing new information regarding the effects of chemical and physical agents on the developing, adult or aging nervous system. In this context, the fields of neurotoxicology and teratology include studies of agent-induced alterations of nervous system function, with a focus on behavioral outcomes and their underlying physiological and neurochemical mechanisms. The Journal publishes original, peer-reviewed Research Reports of experimental, clinical, and epidemiological studies that address the neurotoxicity and/or functional teratology of pesticides, solvents, heavy metals, nanomaterials, organometals, industrial compounds, mixtures, drugs of abuse, pharmaceuticals, animal and plant toxins, atmospheric reaction products, and physical agents such as radiation and noise. These reports include traditional mammalian neurotoxicology experiments, human studies, studies using non-mammalian animal models, and mechanistic studies in vivo or in vitro. Special Issues, Reviews, Commentaries, Meeting Reports, and Symposium Papers provide timely updates on areas that have reached a critical point of synthesis, on aspects of a scientific field undergoing rapid change, or on areas that present special methodological or interpretive problems. Theoretical Articles address concepts and potential mechanisms underlying actions of agents of interest in the nervous system. The Journal also publishes Brief Communications that concisely describe a new method, technique, apparatus, or experimental result.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com